Kerrick C Rees

Oxadiazon Derivatives Elicit Potent Intracellular Growth Inhibition against Toxoplasma gondii by Disrupting Heme Biosynthesis.

Daniel. C. Whitehead, Zhicheng Dou, Kerrick C Rees, 2022, ACS infectious diseases.

Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infection

Daniel. C. Whitehead, I. Hamza, K. Floyd, 2019, bioRxiv.

Modulation of de novo heme production in Toxoplasma essentially controls its infection

Daniel. C. Whitehead, I. Hamza, K. Floyd, 2019 .

Enolase inhibitors as therapeutic leads for Naegleria fowleri infection

Xinmin Yin, Steven W. Millward, C. Pham, 2024, PLoS pathogens.

Enolase inhibitors as therapeutic leads for Naegleria fowleri infection

Xinmin Yin, B. Staker, Steven W. Millward, 2024, bioRxiv.

Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei

Daniel. C. Whitehead, Steven W. Millward, C. Pham, 2023, Pathogens.